TXG
10X Genomics Inc
NASDAQ: TXG · HEALTHCARE · HEALTH INFORMATION SERVICES
$22.05
+9.16% today
Updated 2026-04-30
Market cap
$2.61B
P/E ratio
—
P/S ratio
4.05x
EPS (TTM)
$-0.35
Dividend yield
—
52W range
$8 – $26
Volume
2.4M
10X Genomics Inc (TXG) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-10.70M | $-76.41M | $34.63M | $-217.90M | $-21.37M | $-33.61M | $-15.20M | $6.66M | $136.05M |
| Capital expenditures | $3.76M | $6.71M | $42.77M | $38.39M | $101.28M | $131.66M | $49.52M | $12.39M | $5.93M |
| Depreciation | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $1.66M | $2.66M | $13.33M | $48.63M | $95.96M | $136.85M | $166.95M | $140.75M | $109.12M |
| Free cash flow | $-14.46M | $-83.12M | $-8.14M | $-256.29M | $-122.65M | $-165.27M | $-64.72M | $-5.73M | $130.12M |
| Investing cash flow | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — |
| Dividends paid | $0.00 | $0.00 | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — |
| Net change in cash | $0.00 | $0.00 | — | $212.61M | $-92.81M | $-368.68M | — | — | — |